Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
Increased offer price to $3.65 per share, a $0.55 per share increaseImproved offer unanimously approved by Revance Board of DirectorsCrown to extend tender offer until 11:59 p.m., Eastern Time, on